ArticlePharmaceuticals (Basel, Switzerland)2025

Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [

Kenneth Dahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.